Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 31,578 shares at $289.04 ($9.1M) on 2022-04-13, disclosed to the SEC on 2022-04-14.
Open-market sale of $9.1M VRTX by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $289.04 | 15,789 | $4.6M | 50.0% |
| 2 | $289.04 | 15,789 | $4.6M | 50.0% |
| Total | $289.04 avg | 31,578 | $9.1M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |